Nevro Corp (NVRO): Kapitalisasi marang pendapatan
Nevro Corp. is implementing robotic electrode assembly to enhance implant precision. Management aims to validate the efficacy of its systems across various pain types, while the strategy focuses on cost optimization and maintaining margins. The price/sales multiple reflects the business valuation dynamics, where 0.50 determines the current status of the parameter relative to historical revenue volatility.
Rincian analitis perusahaan Nevro Corporation (NVRO)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Nevro Corp.|NVRO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Nevro Medical|NVRO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Nevro Corporation|NVRO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Nevro|Rasio jangkoan perantara nevro.com
- data bathi lan kelipatan valuasi:
NVRO - Bathi resik|Bathi resik sing dikarepake Nevro Corp.|NVRO - Rasio rega marang bathi|Pangali forward rega marang bathi Nevro Corp|NVRO - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Nevro Corporation|NVRO - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Nevro|NVRO - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan nevro.com|NVRO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Nevro Corp.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:NVRO nevro.com
Investors evaluate the capitalization of Nevro Corp. (NVRO) using the price-to-sales ratio, which determines the price per unit of revenue. Fundamental P/S analysis allows market expectations to be compared with the uniqueness of HF10 technology and the 10 kHz frequency patents that create a technological barrier. The fundamental P/S trend helps identify overbought zones, minimizing the risks of entering at valuation peaks.
Pesaing Nevro Corp.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan avitamedical.com RCEL|Rasio rega marang pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS - Kapitalisasi marang pendapatan|Multiplikator P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corporation)|Rasio rega marang pendapatan Sensus Healthcare Corp|Kapitalisasi marang pendapatan Zynex Corp (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan Inspira Technologies IINN|ICU: Rasio kapitalisasi marang pendapatan|IRIX: Kapitalisasi marang pendapatan|Intelligent Bio Solutions - Kapitalisasi marang volume dodolan|beyondair.net (XAIR) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan PFSA|SSKN (STRATA Skin Sciences Inc.) - Multiplikator P/S|Rega marang dodolan glucotrack.com GCTK|Kapitalisasi marang pendapatan NAOV (NanoVibronix)|Rasio rega marang pendapatan VERO (Venus Concept Corporation)|Rasio rega marang pendapatan Nuwellis, Inc. NUWE|Rasio kapitalisasi pasar marang pendapatan AEMD|ASXC - Rasio rega marang pendapatan|Rega marang dodolan Avinger Inc.|BSGM (BioSig Technologies, Inc) - Kapitalisasi marang pendapatan|Cutera Inc - Rasio kapitalisasi pasar marang pendapatan|KNW (Know Labs, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan inarimedical.com (NARI)|Rasio rega marang pendapatan ReShape Lifesciences (RSLS)|SILK - Rega marang dodolan
